Research libraryMOLEKUL / SOURCE RECORD

RESTORE ME: anhydrous enol-oxaloacetate trial

Cash A et al. · 2024 · Frontiers in Neurology

Indexed 2026-11-12.

Randomized trialFull text availableSource linked

Reported findings and study design

Reported findings

Double-blind trial of anhydrous enol-oxaloacetate 1,000 mg twice daily or rice flour for three months. The designated primary fatigue measure was the Chalder score.

Dose, route and schedule

Double-blind trial of anhydrous enol-oxaloacetate 1,000 mg twice daily or rice flour for three months. The designated primary fatigue measure was the Chalder score.

Protocol source ↗ · Original source

Results · Original full text
MeasureResultComparison, timing and statistics
Chalder fatigue at three monthsFatigue fell 27% from baseline with oxaloacetate. The end-of-study between-group comparison gave p=0.057.
Responder analysisThe authors reported more participants achieving a greater than 25% reduction versus control (p<0.05).

The lead author was an officer of the company funding and commercializing the formulation. The primary between-group comparison was inconclusive at the conventional 0.05 threshold.

Source for these results ↗ · Reviewed 2026-11-12

For research and education. Consult a qualified clinician for medical advice.

Study limitations and source details

Study limitations

  • The lead author was an officer of the company funding and commercializing the formulation. The primary between-group comparison was inconclusive at the conventional 0.05 threshold.

Related publications may cover the same research program or participants.

Source access

Double-blind trial of anhydrous enol-oxaloacetate 1,000 mg twice daily or rice flour for three months. The designated primary fatigue measure was the Chalder score.

Source reviewed 2026-11-12.

Open source ↗

DOI: 10.3389/fneur.2024.1483876

Citation and original source

Original source: Cash A et al.. RESTORE ME: anhydrous enol-oxaloacetate trial Frontiers in Neurology 2024.

Molekul research summary: https://molekul.io/research/oxaloacetate-restore-me-2024. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards